Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles - Archive ouverte HAL
Article Dans Une Revue Journal of Cachexia, Sarcopenia and Muscle Année : 2022

Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles

Udaya Geetha Vijayakumar
  • Fonction : Auteur
Jean Philippe Loeffler
  • Fonction : Auteur
Alexandre Henriques
  • Fonction : Auteur
Adele Hesters
  • Fonction : Auteur
Lucette Lacomblez
  • Fonction : Auteur
Pascal Laforet
  • Fonction : Auteur
Timothee Langlet
  • Fonction : Auteur
Pascal Leblanc
  • Fonction : Auteur
Nadine Le Forestier
  • Fonction : Auteur
Thierry Maisonobe
  • Fonction : Auteur
Vincent Meininger
  • Fonction : Auteur
Laura Robelin
  • Fonction : Auteur
Francois Salachas
  • Fonction : Auteur
Giorgia Querin
  • Fonction : Auteur
Julie Dumonceaux
  • Fonction : Auteur
Stephanie Duguez
  • Fonction : Auteur
  • PersonId : 1103932
Pierre Francois Pradat
  • Fonction : Auteur

Résumé

Background

The cause of the motor neuron (MN) death that drives terminal pathology in amyotrophic lateral sclerosis (ALS) remains unknown, and it is thought that the cellular environment of the MN may play a key role in MN survival. Several lines of evidence implicate vesicles in ALS, including that extracellular vesicles may carry toxic elements from astrocytes towards MNs, and that pathological proteins have been identified in circulating extracellular vesicles of sporadic ALS patients. Because MN degeneration at the neuromuscular junction is a feature of ALS, and muscle is a vesicle-secretory tissue, we hypothesized that muscle vesicles may be involved in ALS pathology. Methods Sporadic ALS patients were confirmed to be ALS according to El Escorial criteria and were genotyped to test for classic gene mutations associated with ALS, and physical function was assessed using the ALSFRS-R score. Muscle biopsies of either mildly affected deltoids of ALS patients (n = 27) or deltoids of aged-matched healthy subjects (n = 30) were used for extraction of muscle stem cells, to perform immunohistology, or for electron microscopy. Muscle stem cells were characterized by immunostaining, RT-qPCR, and transcriptomic analysis. Secreted muscle vesicles were characterized by proteomic analysis, Western blot, NanoSight, and electron microscopy. The effects of muscle vesicles isolated from the culture medium of ALS and healthy myotubes were tested on healthy human-derived iPSC MNs and on healthy human myotubes, with untreated cells used as controls. Results An accumulation of multivesicular bodies was observed in muscle biopsies of sporadic ALS patients by immunostaining and electron microscopy. Study of muscle biopsies and biopsy-derived denervation-naïve differentiated muscle stem cells (myotubes) revealed a consistent disease signature in ALS myotubes, including intracellular accumulation of exosome-like vesicles and disruption of RNA-processing. Compared with vesicles from healthy control myotubes, when administered to healthy MNs the vesicles of ALS myotubes induced shortened, less branched neurites, cell death,

Fichier principal
Vignette du fichier
J Cachexia Sarcopenia Muscle 2022.pdf (23.62 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04767184 , version 1 (05-11-2024)

Licence

Identifiants

Citer

Laura Le Gall, William J Duddy, Cecile Martinat, Virginie Mariot, Owen Connolly, et al.. Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles. Journal of Cachexia, Sarcopenia and Muscle, 2022, 13, pp.1385 - 1402. ⟨10.1002/jcsm.12945⟩. ⟨hal-04767184⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More